Site Search     
Institute of Metabolic Disease
Clinical Tests
List of Clinical Tests and Requisition Forms (PDF)
Research Tests
Diseases and Related Tests
Supplemental Newborn Screening
Tests Available for New York Clients
Shipping Information
Prices and CPT Codes
Accreditations/Licensures
Our Staff
Contact Us
Complete Our Satisfaction Survey
Supporting the Institute

 


Institute of Metabolic Disease at Baylor Research Institute
Charles R. Roe, M.D.

Medical Director of Institute of Metabolic Disease
Professor of Biomedical Studies, Baylor University


Contact Information:
Phone: 214-820-4855

Education:
B.A. Duke University
M.D. Duke University Medical Center
Biochemistry Dept, Brandeis University
Residency/Fellowship in Pediatric Metabolism, Duke University

Research Interests:
• Biochemical Genetics- Fat Oxidation, Organic Acidurias, Glycogenoses
• Acquired Metabolic Disorders of Children and Adults
• Investigation for Developing More Effective Treatment of Fat Oxidation Defects, Organic Acidurias, and Glycogenoses

Current Research:
Collaborative studies nationally and internationally for development of new effective therapies for inherited and acquired disorders of metabolism. Current emphasis is on disorders affecting branched-chain amino acids, fat oxidation, and glycogenoses.

Ongoing Research Studies:
The Institute of Metabolic Disease at Baylor is currently conducting a research study entitled, “Dietary Therapy for Inherited Disorders of Mitochondrial Fat Oxidation and Glycogenoses.”

To learn more about the study, contact Dr. Roe or Mary Wallace at (214) 820-4533.

Representative Publications:
Mochel, F., DeLonlay, P., Touati, G., Brunengraber, H., Kinman, R., D., Roe, C.R., Saudubray, J. Pyruvate Carboxylase deficiency: clinical and biochemical response to anaplerotic diet therapy. Molecular Genetics and Metabolism. Volume 84: 305-312, 2005.

Roe, C.R. and Ding, J.H.: Mitochondrial Fatty Acid Oxidation Disorders. The Metabolic and Molecular Bases of Inherited Diseases, 8th edition, Chapter 101, pp 2297-2326, McGraw-Hill, 2001.

Roe, C.R., Sweetman, L., Roe, D.S., David, F., Brunegraber, H. Effective Dietary Treatment of Cardiomyopathy & Rhabdomyolysis in Long-Chain Fax Oxidation Disorders using an Anaplerotic Odd-Chain Triglyceride. J. Clin. Invest 110 (2): 259-269, 2002.